The Effect of Hemodialysis Treatment on Self-Care Power and Disease Adjustment of Patients

May 25, 2022 updated by: Abdullah Gerçek

The Effect of Self-Care Supported Motivational Interviewing on Patients' Self-Care Strength and Disease Adjustment in Patients Receiving Hemodialysis Treatment

The study was conducted to determine the effect of self-care supported motivational interviewing on patients receiving hemodialysis treatment on self-care power, disease compliance and metabolic variables.

The study was completed with 77 patients. In the collection of data; Personal Information Form, Self-Care Strength Scale, Chronic Disease Adjustment Scale and Patient-Specific Metabolic Variables Form were used.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The study was conducted as a randomized controlled, repeated measurement, experimental research design.

The research was carried out in Muş Provincial Health Directorate Muş State Hospital Hemodialysis Unit between October 2020 and March 2021. There are 6 nurses, 7 dialysis technicians, 5 assistant health personnel, 2 specialist physicians, 28 patient beds and 28 hemodialysis machines in the hemodialysis unit where the research was conducted. In the hemodialysis unit, there are 1 waiting room where patients and their attendants wait, 4 private rooms and 2 large halls where patients receive hemodialysis treatment. There is no attempt at motivational interviewing in the hemodialysis center where the research was conducted.

The population of the study consisted of 97 patients who received hemodialysis treatment at the Muş Provincial Health Directorate, Muş State Hospital, Hemodialysis Unit on the specified dates. The sample of the research is "G. Using the "Power-3.1.9.2" program and based on similar articles, 80% power was determined at an effect size of 0.70 and it was calculated to have a minimum of 68 subjects in total. In the hemodialysis unit where the research was conducted, 85 patients who met the research criteria and volunteered to participate in the research were formed because 2 patients did not attend hemodialysis treatment regularly, 4 patients did not want to participate in the study, 3 patients had poor general health conditions, 2 patients had hearing problems, and 1 patient was transferred to another dialysis center. . Using the simple random sampling method, 45 patients were assigned to the experimental group and 40 patients to the control group. However, during the research period, the study was completed with 37 patients in the control group, as 40 patients in the experimental group and 3 patients in the control group died due to the death of 2 patients from the experimental group, the death of 2 patients and the transfer of 1 patient to another hemodialysis center during the research period.

Study Type

Interventional

Enrollment (Actual)

87

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • MUŞ, Turkey, 49000_
        • Mus State Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Receiving hemodialysis treatment for at least three months at the time of the study,
  2. HD treatment for 3-4 hours 2 or 3 days a week,
  3. 18 years old and above,
  4. Open to communication and cooperation,
  5. Not visually or hearing impaired,
  6. Being a reader and writer,
  7. Not having any psychiatric diagnosis and/or not using any psychiatric medication,
  8. Have not received motivational interviewing training before,
  9. Individuals who agreed to participate in the study were included in the study.

Exclusion Criteria:

  1. who are under the age of 18,
  2. Having a communication problem,
  3. Individuals who did not want to participate in the study or did not want to continue were excluded from the study.ı

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: control
The control group did not intervene
After the pre-test data were applied to all patients, before starting the motivational interview seans, the patients were informed about the interview intervals, duration, and how many times they would be held. In the second week, motivational interview seans were started with the patients. seans with patients took place during the hemodialysis seans. A total of 6 seans were held, one seans per week. After the first seans of the self-care supported motivational interview, the "Self-Care and Adaptation to Disease Training Guide" prepared by the researcher in line with the literature was given to the experimental group. Self-care training was given in the first, second and third seans. Motivational interviews were conducted in the fourth, fifth and sixth seans. Motivational interviewing techniques were used for patients to realize their self-care activities. seans were held individually with the patients and each seans lasted approximately 15-20 minutes.
Experimental: experiment
Initial data were collected after meeting the patients. Then, a total of 6 seans, 1 seans per week, were performed on the patients. Self-care training was given in the 1st, 2nd and 3rd seans. Motivational interviews were conducted in the 4th, 5th and 6th seans. After the first seans of the self-care supported motivational interview, the "Self Care and Adaptation Training Guide" prepared by the researcher in line with the literature was given to the experimental group. Second data were collected from patients after 6 weeks. Follow-up data were collected for 4 weeks without any intervention.
After the pre-test data were applied to all patients, before starting the motivational interview seans, the patients were informed about the interview intervals, duration, and how many times they would be held. In the second week, motivational interview seans were started with the patients. seans with patients took place during the hemodialysis seans. A total of 6 seans were held, one seans per week. After the first seans of the self-care supported motivational interview, the "Self-Care and Adaptation to Disease Training Guide" prepared by the researcher in line with the literature was given to the experimental group. Self-care training was given in the first, second and third seans. Motivational interviews were conducted in the fourth, fifth and sixth seans. Motivational interviewing techniques were used for patients to realize their self-care activities. seans were held individually with the patients and each seans lasted approximately 15-20 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
self care power scale
Time Frame: 6 week
ıt is a scale used to measure an invidual's self-care abilit. the maximum score is 140. the hiğher the score obtained from the scale indicates the hiğh level of self-care ability and power of the invidual.
6 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chronic Disease Adjustment Scale
Time Frame: 6 week
The scale was developed to measure the level of compliance of individuals with chronic diseases. The total score that can be obtained from the scale is 125. An increase in the scores obtained from the sub-dimensions and/or the whole scale means that the patients' level of compliance with the disease also increases.
6 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: abdullah gerçek, doktora, Muş Alparslan University
  • Study Director: serap parlar kılıç, Inonu University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 2, 2020

Primary Completion (Actual)

November 20, 2020

Study Completion (Actual)

March 15, 2021

Study Registration Dates

First Submitted

September 27, 2021

First Submitted That Met QC Criteria

May 25, 2022

First Posted (Actual)

June 1, 2022

Study Record Updates

Last Update Posted (Actual)

June 1, 2022

Last Update Submitted That Met QC Criteria

May 25, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • MUŞ ALPARSLAN UNIVERSITY

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

no, not shared with other people

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemodialysis Complication

Clinical Trials on motivational interview

Subscribe